These researchers reported that the regional intraventricular delivery of HER2-redirected CAR-Ts resulted in promising therapeutic responses against leptomeningeal disease and brain-metastasized breast cancer in human xenograft mouse models (106). The gene discussed is ERBB2; the disease is breast cancer.